Office of Research and Development Coordination

Project BioShield

Please note that documents in PDF format require Adobe's Acrobat Reader

Project BioShield was announced by President Bush in his State of the Union address on 28 January 2003. The purpose of this bill is to accelerate the process of research, development, purchase, and availability of effective countermeasures against agents of bioterror. Secretaries Thompson (HHS) and Ridge (DHS) jointly transmitted the "Project BioShield Act of 2003 to Congress on 26 February 2003.

• The House version of the bill (H.R. 2122) was passed by a vote of 421-2 on 16 July 2003.
• The Senate version of the bill (S. 15) was passed by a vote of 99-0 on 19 May 2004.
• The bill (P.L. 108-276) was signed by the President on 21 July 2004.
  
  

The Office of Research and Development Coordination (ORDC), within the Office of Public Health and Emergency Preparedness (OPHEP), has procuring authority for Project BioShield Acquisitions.

• Project BioShield Procurement Projects



• Other Public Health and Emergency Preparedness Procurement Projects



• FAQs



• Project BioShield In the News



• Other Links of interest: CDC, NIAID, Strategic National Stockpile (SNS), FDA, HHS, Federal Business Opportunities, DARPA

Events Where You Can Find Us

• Federal Biodefense Research 2005 [PDF 622K] 21 October 2004
• Phacilitate Vaccine Forum Fall 2004 3 November 2004
• 2005 World Vaccine Congress, 19-20 April 2005

HHS Home | Questions? | Contact HHS | Site Map | Accessibility | Privacy Policy | Freedom of Information Act | Disclaimers

The White House | FirstGov

U.S. Department of Health & Human Services · 200 Independence Avenue, S.W. · Washington, D.C. 20201